InsidersTradesSigma
Track the 迪安诊断 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 迪安诊断 has logged 5 public disclosures. Market capitalisation: €12.7bn. The latest transaction was reported on 22 July 2026 (Purchase). Among the most active insiders: 陈海斌. The full history is free.
5
Insider Decl.
n/a
Thresholds
€2,965
1 ops.
Buy Volume
€18m
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 迪安诊断 Hold (neutral), based on 6 analysts. Average price target: CN¥19.24.
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,430 of 28,803 companies
43.1
score / 100
Value50
Quality36
FCF yld14%
Earn yld0.4%
EV/EBITDA17.1x
ROE4.5%
Gross mgn28%
Net mgn0.4%
Debt/EBITDA3.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 July 2026
Declarations5 total
5 of 5 declarations
About 迪安诊断
迪安诊断 is a company specializing in medical diagnostic services in China. It offers laboratory tests and health solutions to enhance the diagnosis and treatment of diseases.